Bill restricting biotechs from working with certain China-affiliated companies is a political stunt rooted in xenophobia
Protecting Americans’ DNA from foreign exploitation — indeed, from any exploitation — is a laudable goal. But Congress’ latest proposal restricting biotechs from working with certain firms and suppliers is an ineffective result of xenophobia and political fearmongering.
In 2013, a Chinese group acquired CG — with U.S. government approval. Today we are a subsidiary of MGI, publicly traded on the Shanghai stock exchange. To the proponents of BIOSECURE, this now forms the basis of a sinister sci-fi narrative in which CG has access to Americans’ genetic information and will use it for nefarious purposes.
Illumina already controls 80% of the U.S. genomics market. BIOSECURE will expand that dominance, resulting in less competition, higher prices and fewer choices. It will leave the U.S. health care and biotech industries with no access to our advanced sequencing platform. Ironically, while Congress targets CG, Illumina is drawing closer to China.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Non-Americans Married To Americans Share Differences'There's a pressure to be perfect in American life that makes having difficult emotional conversations, at least for his family, almost impossible.'
Read more »
Opinion: The Right Wing Is Attacking Queer & Trans Americans to Distract From Their Bigger AgendaCongressman Greg Casar on taking the fight for LGBTQIA+ Texans to the national level
Read more »
Opinion: Medicare for hearing aids could change millions of older Americans’ livesHearing loss affects communication, relationships and daily life, yet devices’ high cost remain a barrier to treatment.
Read more »
Trump verdict, Americans stand with Israel and more from Fox News OpinionRead the latest from Fox News Opinion and watch videos from Sean Hannity, Raymond Arroyo and more.
Read more »
Will Biden's Ceasefire Plan End Hostilities Between Israel and Hamas?See multiple perspectives from New York Post (Opinion), CNN (Opinion), and Reuters at AllSides.com.
Read more »
Did Biden's Border Executive Order Increase His Reelection Chances?See multiple perspectives from National Review (Opinion), New York Times (Opinion), and Reuters at AllSides.com.
Read more »